SVKM’s NMIMS (Deemed-to-be University) inaugurated its state-of-the-art High-Performance Computing (HPC) facility at the Sunandan Divatia School of Science.
The launch of this HPC facility seemingly underscores the University’s commitment toward strengthening advanced computational research and training in computational biology and interdisciplinary life-science research. This state-of-the-art facility has been established with generous funding support from the Indian Council of Medical Research (ICMR) and SVKM’s NMIMS, reflecting a shared commitment to promoting high-end computational infrastructure in biomedical and translational research.
The newly inaugurated HPC facility will support cutting-edge research in areas such as molecular modelling and simulations, drug discovery, genomics, and artificial intelligence–driven biological data analysis. The facility is expected to serve as a hub for research, training, and collaborative projects with academic, clinical, and industry partners, contributing meaningfully to the national research ecosystem. The facility will also enable skill development, interdisciplinary collaboration, and academic research among faculty, students, and external research partners.
University officials highlighted that the HPC facility will play a pivotal role in enhancing research capabilities, fostering interdisciplinary collaboration, and building computational skills among students and faculty. The initiative aligns with NMIMS’ commitment to academic excellence, innovation, and impactful research, while complementing ICMR’s mission to advance healthcare and biomedical research through scientific infrastructure development.
Recently, NMIMS organised a National Conference on Computational Biology and Artificial Intelligence in Drug Discovery – 2026 (CBAIDD-26). The conference, supported by Anusandhan National Research Foundation, provides a collaborative platform for academia and industry to explore emerging tools such as machine learning, molecular simulations, and data-driven modelling, fostering translational research and accelerating Al-enabled drug discovery and precision healthcare.
The two-day conference served as a platform for knowledge exchange and collaborative dialogue. The national conference featured talks by eminent speakers from premier institutions such as IIT Bombay, JNU Delhi, NIPER Mohali, IISER Pune, CDAC Pune, TIFR, IIT BHU, IIIT Delhi, ACTREC, University of Delhi, and NIRRCH, showcasing a depth of expertise along with opportunities for meaningful academic–industry interaction.
The aim of the conference was to foster interdisciplinary collaboration, promote translational research and healthcare applications, showcase breakthroughs and innovations, while bridging the gap between academia, industry, and clinicians. It acted as a platform to bring together researchers, academicians, industry professionals, and students to discuss recent advances and emerging trends in computational biology, AI and machine learning in biology, genomics, proteomics, artificial intelligence, NGS data analysis, and drug discovery, with a strong emphasis on interdisciplinary research and innovation in healthcare.
Dr Jayakumar Singh Bondili, Dean, Sunandan Divatia School of Science, NMIMS, said, “CBAIDD-26 reflects our vision of integrating artificial intelligence with life sciences to address the various challenges in healthcare and share knowledge on drug discovery. The inauguration of the HPC facility also marks a significant step for our institution as it helps us empower students, researchers, and faculty with advanced technology and state-of-the-art infrastructure. We are looking forward to continuing contributing meaningfully to the drug discovery research in India while advancing our biomedical research.” |